Friday 25 May |
Hochschild Mining |
Ferrexpo |
Keywords Studios |
Lookers |
Informa |
Spectris |
ContourGlobal |
Old Mutual (re managed separation) |
Monday 28 May |
no events scheduled |
Tuesday 29 May |
Afarak group |
Belvoir Lettings |
Eddie Stobart Group |
Standard Life Aberdeen |
Oxford Biomedica |
Harworth Group |
Playtech (re acquisition of Snaitech) |
Wednesday 30 May |
AG Barr |
Bodycote |
Crudader Resources |
Royal Bank of Scotland Group |
Frenkel Topping Group |
Safestyle UK |
Fresnillo |
Thursday 31 May |
Brady |
Card Factory |
e-Therapeutics |
Faron Pharmaceuticals |
Porta Communications |
Total Produce |
Northbridge Industrial |
Sirius Minerals |
Faron Pharmaceuticals confirms publication of 'crucial' study
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Wednesday that the results of its detailed analyses into the effects of glucocorticoids on intravenous interferon beta-1a activity, which arose following the 'INTEREST' trial in 2018, had been published in critical care journal Intensive Care Medicine.
Read more